drugset / Trial / NCT05321160

Comparison of the Sedation Effect of Esketamine and Sevoflurane for Pediatric Ophthalmological Procedure

NCT05321160

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Emergence agitation is the most common reason for post-anesthesia care unit delay. Sevoflurane is used frequently inhalational anaesthetic agent to provide pediatric anaesthesia because of the nonirritant nature. It has been successfully used for keeping spontaneous breathing without tracheal intubation. However, sevoflurane may cause emergence agitation as the incidence varied from 10%-80%. Although there are many sedative agents to reduce its incidence, such as propofol, midazolam, a2 adrenergic receptor agonists and ketamine, the efficacy remains limited. Ketamine, a neuroleptic anesthetic agent, contains two optical isomers, s(+)-ketamine (esketamine) and R(-)-ketamine. Esketamine is a right-handed split of ketamine, which has enhanced analgesic potency and lower incidence of psychotropic side effects compared to ketamine. It stimulate breathing due to N-Methyl-D-Aspartate receptor blockade, and could even effectively countered remifentanil-induced respiratory depression. The investigators compared the effectiveness of esketamine and sevoflurane in reducing the incidence of emergence agitation after painless ophthalmological procedure in pediatric patients.

Timeline

Start
2022-03-28
Primary completion
2023-05-14
Completion
2023-05-17

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Esketamine Other / unclassified 0.25 mg/kg Intravenous
Comparator Sevoflurane Other / unclassified 2 % Inhaled
Comparator Sevoflurane Other / unclassified 4 % Inhaled

Indications

No indication recorded.